It is crucial to have a continuous supply of chromatography resins, even under unforeseen circumstances. To help you maintain manufacturing of vital biopharmaceuticals, Capto resins come with GE’s security of supply program and comprehensive regulatory and application support.
A diversified pipeline creates new needs
Diversity is increasing in today’s biopharmaceutical pipeline. With many different types of molecules, it is difficult to use a platform approach for purification. Instead, you need to use a broad range of techniques including affinity, IEX, HIC, and multimodal chromatography.
Within therapeutic areas, like gene therapy and vaccines, the molecules purified adds new hurdles in the purification process. The large size and diversity of these molecules challenge the capacity and resolution of the resin.